Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-fibrotic Agents for Fibrosis Regression in HCV SVR Patients
NCT03659058Completed
- Sponsor
- Zagazig University
- Start
- Mar 2016
- Primary completion
- Aug 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Randomised, open-label trial of silymarin, ursodeoxycholic acid and colchicine in Liver cirrhosis (LC), sponsored by Zagazig University. Primary endpoint: Liver stiffness measurement by Fibroscan at 1 year. Started Mar 2016; status: completed.
02
Drugs
silymarinursodeoxycholic acidcolchicine
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03659058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659058.